668
Views
0
CrossRef citations to date
0
Altmetric
Coronavirus

The impact of previous SARS-CoV-2 infection on post-vaccine adverse events in individuals vaccinated with TURKOVAC or CoronaVac –inactivated COVID-19 vaccines

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & show all, , , , , , , , , , , , , , , , , & show all
Article: 2346388 | Received 05 Oct 2023, Accepted 19 Apr 2024, Published online: 26 Jun 2024

Figures & data

Table 1. Adverse events in demographic subgroups of participants with and without COVID-19 disease history before the vaccine application.

Table 2. Timing of adverse events after first dose of TURKOVAC in participants with and without COVID-19 disease history.

Table 3. Adverse events after the second dose of COVID-19 vaccination in participants with and without COVID-19 disease history.

Table 4. Timing of adverse events in the TURKOVAC and CoronaVac groups with and without COVID-19 disease history.

Data availability statement

Proposals should be submitted to the sponsor, Health Institutes of Türkiye, who holds all the financial and intellectual rights of the study and the study vaccine TURKOVAC.